Articles on Physician-Directed Marketing Last updated November 8, 2004 home > Physicians and Pharmaceutical Marketing > Articles

This page is under construction.

Since other resources exhaustively catalogue available articles, I'll use this section to post articles that are recent (and in my opinion compelling) contributions to the growing literature. Contents will change over time.

Editorials

Blumenthal, David. Doctors and drug companies. N Engl J Med 2004;351(18):1885-1890.

The most salient of Blumenthal's many editorials, this article summarizes the last decade of physician-pharmaceutical interactions and cites the numbers we've come to know and love: The drug industry spent 33% of revenues on "selling adn administration" in 2002, which is between $12 and $15 billion, or $8,000 to $15,000 per physician.

Studdert, David M., Michelle M. Mello, and Troyen A. Brennan. Financial conflicts of interest in physicians' relationships with the pharmaceutical industry -- self-regulation in the shadow of federal prosecution. N Engl J Med 2004;351(18):1891-1900.

Studdert et al summarize the development of law governing physician-industry relations and include a table summarizing recent conflict-of-interest guidelines from PhRMA, AMA, ACCME, ACP, and OIG.

Evidence